Japan Biosimilar Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Biosimilar market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Biosimilar market. Detailed analysis of key players, along with key growth strategies adopted by Biosimilar industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.


    By Player:

    • CP Guojian Pharmacy

    • Teva Pharmaceutical

    • Hospira (Boehringer Ingelheim)

    • SANDOZ (NOVARTIS)

    • Gelgen Biopharma

    • MYLAN

    • Changchun High Tech

    • Biotech Pharma

    • 3sbio

    • Sun pharma


    By Type:

    • Type 1

    • Type 2

    • Type 3


    By End-User:

    • End-Users 1

    • End-Users 2

    • End-Users 3


    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Biosimilar Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Biosimilar Market Size and Growth Rate of Type 1 from 2014 to 2026

      • 1.3.2 Japan Biosimilar Market Size and Growth Rate of Type 2 from 2014 to 2026

      • 1.3.3 Japan Biosimilar Market Size and Growth Rate of Type 3 from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Biosimilar Market Size and Growth Rate of Application 1 from 2014 to 2026

      • 1.4.2 Japan Biosimilar Market Size and Growth Rate of Application 2 from 2014 to 2026

      • 1.4.3 Japan Biosimilar Market Size and Growth Rate of Application 3 from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Biosimilar Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Biosimilar Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Biosimilar Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Biosimilar Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Biosimilar Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Biosimilar Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Biosimilar Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Biosimilar Consumption Market Size and Growth Rate from 2014 to 2026


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Biosimilar Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Biosimilar by Major Types

      • 3.4.1 Market Size and Growth Rate of Type 1

      • 3.4.2 Market Size and Growth Rate of Type 2

      • 3.4.3 Market Size and Growth Rate of Type 3


    4 Segmentation of Biosimilar Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Biosimilar by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Biosimilar in Application 1

      • 4.4.2 Market Size and Growth Rate of Biosimilar in Application 2

      • 4.4.3 Market Size and Growth Rate of Biosimilar in Application 3


    5 Market Analysis by Regions

    • 5.1 Japan Biosimilar Production Analysis by Regions

    • 5.2 Japan Biosimilar Consumption Analysis by Regions


    6 Hokkaido Biosimilar Landscape Analysis

    • 6.1 Hokkaido Biosimilar Landscape Analysis by Major Types

    • 6.2 Hokkaido Biosimilar Landscape Analysis by Major End-Users


    7 Tohoku Biosimilar Landscape Analysis

    • 7.1 Tohoku Biosimilar Landscape Analysis by Major Types

    • 7.2 Tohoku Biosimilar Landscape Analysis by Major End-Users


    8 Kanto Biosimilar Landscape Analysis

    • 8.1 Kanto Biosimilar Landscape Analysis by Major Types

    • 8.2 Kanto Biosimilar Landscape Analysis by Major End-Users


    9 Chubu Biosimilar Landscape Analysis

    • 9.1 Chubu Biosimilar Landscape Analysis by Major Types

    • 9.2 Chubu Biosimilar Landscape Analysis by Major End-Users


    10 Kinki Biosimilar Landscape Analysis

    • 10.1 Kinki Biosimilar Landscape Analysis by Major Types

    • 10.2 Kinki Biosimilar Landscape Analysis by Major End-Users


    11 Chugoku Biosimilar Landscape Analysis

    • 11.1 Chugoku Biosimilar Landscape Analysis by Major Types

    • 11.2 Chugoku Biosimilar Landscape Analysis by Major End-Users


    12 Shikoku Biosimilar Landscape Analysis

    • 12.1 Shikoku Biosimilar Landscape Analysis by Major Types

    • 12.2 Shikoku Biosimilar Landscape Analysis by Major End-Users


    13 Kyushu Biosimilar Landscape Analysis

    • 13.1 Kyushu Biosimilar Landscape Analysis by Major Types

    • 13.2 Kyushu Biosimilar Landscape Analysis by Major End-Users


    14 Major Players Profiles

    • 14.1 CP Guojian Pharmacy

      • 14.1.1 CP Guojian Pharmacy Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 Teva Pharmaceutical

      • 14.2.1 Teva Pharmaceutical Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 Hospira (Boehringer Ingelheim)

      • 14.3.1 Hospira (Boehringer Ingelheim) Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 SANDOZ (NOVARTIS)

      • 14.4.1 SANDOZ (NOVARTIS) Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 Gelgen Biopharma

      • 14.5.1 Gelgen Biopharma Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

    • 14.6 MYLAN

      • 14.6.1 MYLAN Company Profile and Recent Development

      • 14.6.2 Market Performance

      • 14.6.3 Product and Service Introduction

    • 14.7 Changchun High Tech

      • 14.7.1 Changchun High Tech Company Profile and Recent Development

      • 14.7.2 Market Performance

      • 14.7.3 Product and Service Introduction

    • 14.8 Biotech Pharma

      • 14.8.1 Biotech Pharma Company Profile and Recent Development

      • 14.8.2 Market Performance

      • 14.8.3 Product and Service Introduction

    • 14.9 3sbio

      • 14.9.1 3sbio Company Profile and Recent Development

      • 14.9.2 Market Performance

      • 14.9.3 Product and Service Introduction

    • 14.10 Sun pharma

      • 14.10.1 Sun pharma Company Profile and Recent Development

      • 14.10.2 Market Performance

      • 14.10.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 110 Figures and 188 Tables)

     

    • Figure Japan Biosimilar Market Size and Growth Rate of Type 1 from 2014 to 2026

    • Figure Japan Biosimilar Market Size and Growth Rate of Type 2 from 2014 to 2026

    • Figure Japan Biosimilar Market Size and Growth Rate of Type 3 from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Biosimilar Market Size and Growth Rate of Application 1 from 2014 to 2026

    • Figure Japan Biosimilar Market Size and Growth Rate of Application 2 from 2014 to 2026

    • Figure Japan Biosimilar Market Size and Growth Rate of Application 3 from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Biosimilar Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Biosimilar Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Biosimilar Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Biosimilar Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Biosimilar Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Biosimilar Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Biosimilar Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Biosimilar Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Biosimilar Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Biosimilar

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Biosimilar by Different Types from 2014 to 2026

    • Table Consumption Share of Biosimilar by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Type 1

    • Figure Market Size and Growth Rate of Type 2

    • Figure Market Size and Growth Rate of Type 3

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Biosimilar by Different End-Users from 2014 to 2026

    • Table Consumption Share of Biosimilar by Different End-Users from 2014 to 2026

    • Figure Japan Biosimilar Market Size and Growth Rate of Application 1 from 2014 to 2026

    • Figure Japan Biosimilar Market Size and Growth Rate of Application 2 from 2014 to 2026

    • Figure Japan Biosimilar Market Size and Growth Rate of Application 3 from 2014 to 2026

    • Table Japan Biosimilar Production by Regions

    • Table Japan Biosimilar Production Share by Regions

    • Figure Japan Biosimilar Production Share by Regions in 2014

    • Figure Japan Biosimilar Production Share by Regions in 2018

    • Figure Japan Biosimilar Production Share by Regions in 2026

    • Table Japan Biosimilar Consumption by Regions

    • Table Japan Biosimilar Consumption Share by Regions

    • Figure Japan Biosimilar Consumption Share by Regions in 2014

    • Figure Japan Biosimilar Consumption Share by Regions in 2018

    • Figure Japan Biosimilar Consumption Share by Regions in 2026

    • Table Hokkaido Biosimilar Consumption by Types from 2014 to 2026

    • Table Hokkaido Biosimilar Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Biosimilar Consumption Share by Types in 2014

    • Figure Hokkaido Biosimilar Consumption Share by Types in 2018

    • Figure Hokkaido Biosimilar Consumption Share by Types in 2026

    • Table Hokkaido Biosimilar Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Biosimilar Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Biosimilar Consumption Share by End-Users in 2014

    • Figure Hokkaido Biosimilar Consumption Share by End-Users in 2018

    • Figure Hokkaido Biosimilar Consumption Share by End-Users in 2026

    • Table Tohoku Biosimilar Consumption by Types from 2014 to 2026

    • Table Tohoku Biosimilar Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Biosimilar Consumption Share by Types in 2014

    • Figure Tohoku Biosimilar Consumption Share by Types in 2018

    • Figure Tohoku Biosimilar Consumption Share by Types in 2026

    • Table Tohoku Biosimilar Consumption by End-Users from 2014 to 2026

    • Table Tohoku Biosimilar Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Biosimilar Consumption Share by End-Users in 2014

    • Figure Tohoku Biosimilar Consumption Share by End-Users in 2018

    • Figure Tohoku Biosimilar Consumption Share by End-Users in 2026

    • Table Kanto Biosimilar Consumption by Types from 2014 to 2026

    • Table Kanto Biosimilar Consumption Share by Types from 2014 to 2026

    • Figure Kanto Biosimilar Consumption Share by Types in 2014

    • Figure Kanto Biosimilar Consumption Share by Types in 2018

    • Figure Kanto Biosimilar Consumption Share by Types in 2026

    • Table Kanto Biosimilar Consumption by End-Users from 2014 to 2026

    • Table Kanto Biosimilar Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Biosimilar Consumption Share by End-Users in 2014

    • Figure Kanto Biosimilar Consumption Share by End-Users in 2018

    • Figure Kanto Biosimilar Consumption Share by End-Users in 2026

    • Table Chubu Biosimilar Consumption by Types from 2014 to 2026

    • Table Chubu Biosimilar Consumption Share by Types from 2014 to 2026

    • Figure Chubu Biosimilar Consumption Share by Types in 2014

    • Figure Chubu Biosimilar Consumption Share by Types in 2018

    • Figure Chubu Biosimilar Consumption Share by Types in 2026

    • Table Chubu Biosimilar Consumption by End-Users from 2014 to 2026

    • Table Chubu Biosimilar Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Biosimilar Consumption Share by End-Users in 2014

    • Figure Chubu Biosimilar Consumption Share by End-Users in 2018

    • Figure Chubu Biosimilar Consumption Share by End-Users in 2026

    • Table Kinki Biosimilar Consumption by Types from 2014 to 2026

    • Table Kinki Biosimilar Consumption Share by Types from 2014 to 2026

    • Figure Kinki Biosimilar Consumption Share by Types in 2014

    • Figure Kinki Biosimilar Consumption Share by Types in 2018

    • Figure Kinki Biosimilar Consumption Share by Types in 2026

    • Table Kinki Biosimilar Consumption by End-Users from 2014 to 2026

    • Table Kinki Biosimilar Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Biosimilar Consumption Share by End-Users in 2014

    • Figure Kinki Biosimilar Consumption Share by End-Users in 2018

    • Figure Kinki Biosimilar Consumption Share by End-Users in 2026

    • Table Chugoku Biosimilar Consumption by Types from 2014 to 2026

    • Table Chugoku Biosimilar Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Biosimilar Consumption Share by Types in 2014

    • Figure Chugoku Biosimilar Consumption Share by Types in 2018

    • Figure Chugoku Biosimilar Consumption Share by Types in 2026

    • Table Chugoku Biosimilar Consumption by End-Users from 2014 to 2026

    • Table Chugoku Biosimilar Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Biosimilar Consumption Share by End-Users in 2014

    • Figure Chugoku Biosimilar Consumption Share by End-Users in 2018

    • Figure Chugoku Biosimilar Consumption Share by End-Users in 2026

    • Table Shikoku Biosimilar Consumption by Types from 2014 to 2026

    • Table Shikoku Biosimilar Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Biosimilar Consumption Share by Types in 2014

    • Figure Shikoku Biosimilar Consumption Share by Types in 2018

    • Figure Shikoku Biosimilar Consumption Share by Types in 2026

    • Table Shikoku Biosimilar Consumption by End-Users from 2014 to 2026

    • Table Shikoku Biosimilar Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Biosimilar Consumption Share by End-Users in 2014

    • Figure Shikoku Biosimilar Consumption Share by End-Users in 2018

    • Figure Shikoku Biosimilar Consumption Share by End-Users in 2026

    • Table Kyushu Biosimilar Consumption by Types from 2014 to 2026

    • Table Kyushu Biosimilar Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Biosimilar Consumption Share by Types in 2014

    • Figure Kyushu Biosimilar Consumption Share by Types in 2018

    • Figure Kyushu Biosimilar Consumption Share by Types in 2026

    • Table Kyushu Biosimilar Consumption by End-Users from 2014 to 2026

    • Table Kyushu Biosimilar Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Biosimilar Consumption Share by End-Users in 2014

    • Figure Kyushu Biosimilar Consumption Share by End-Users in 2018

    • Figure Kyushu Biosimilar Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of CP Guojian Pharmacy

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CP Guojian Pharmacy

    • Figure Sales and Growth Rate Analysis of CP Guojian Pharmacy

    • Figure Revenue and Market Share Analysis of CP Guojian Pharmacy

    • Table Product and Service Introduction of CP Guojian Pharmacy

    • Table Company Profile and Development Status of Teva Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Teva Pharmaceutical

    • Figure Revenue and Market Share Analysis of Teva Pharmaceutical

    • Table Product and Service Introduction of Teva Pharmaceutical

    • Table Company Profile and Development Status of Hospira (Boehringer Ingelheim)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hospira (Boehringer Ingelheim)

    • Figure Sales and Growth Rate Analysis of Hospira (Boehringer Ingelheim)

    • Figure Revenue and Market Share Analysis of Hospira (Boehringer Ingelheim)

    • Table Product and Service Introduction of Hospira (Boehringer Ingelheim)

    • Table Company Profile and Development Status of SANDOZ (NOVARTIS)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SANDOZ (NOVARTIS)

    • Figure Sales and Growth Rate Analysis of SANDOZ (NOVARTIS)

    • Figure Revenue and Market Share Analysis of SANDOZ (NOVARTIS)

    • Table Product and Service Introduction of SANDOZ (NOVARTIS)

    • Table Company Profile and Development Status of Gelgen Biopharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gelgen Biopharma

    • Figure Sales and Growth Rate Analysis of Gelgen Biopharma

    • Figure Revenue and Market Share Analysis of Gelgen Biopharma

    • Table Product and Service Introduction of Gelgen Biopharma

    • Table Company Profile and Development Status of MYLAN

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of MYLAN

    • Figure Sales and Growth Rate Analysis of MYLAN

    • Figure Revenue and Market Share Analysis of MYLAN

    • Table Product and Service Introduction of MYLAN

    • Table Company Profile and Development Status of Changchun High Tech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Changchun High Tech

    • Figure Sales and Growth Rate Analysis of Changchun High Tech

    • Figure Revenue and Market Share Analysis of Changchun High Tech

    • Table Product and Service Introduction of Changchun High Tech

    • Table Company Profile and Development Status of Biotech Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biotech Pharma

    • Figure Sales and Growth Rate Analysis of Biotech Pharma

    • Figure Revenue and Market Share Analysis of Biotech Pharma

    • Table Product and Service Introduction of Biotech Pharma

    • Table Company Profile and Development Status of 3sbio

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of 3sbio

    • Figure Sales and Growth Rate Analysis of 3sbio

    • Figure Revenue and Market Share Analysis of 3sbio

    • Table Product and Service Introduction of 3sbio

    • Table Company Profile and Development Status of Sun pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sun pharma

    • Figure Sales and Growth Rate Analysis of Sun pharma

    • Figure Revenue and Market Share Analysis of Sun pharma

    • Table Product and Service Introduction of Sun pharma

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.